Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Validity of Using a Novel Artificial Intelligence Platform to Monitor and Optimize Medication Adherence in Patients Receiving Opioid Replacement Therapy

NCT02243670 is registered in ClinicalTrials.gov with AiCure as lead sponsor.

NCT NCT02243670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02243670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Validity of Using a Novel Artificial Intelligence Platform to Monitor and Optimize Medication Adherence in Patients Receiving Opioid Replacement Therapy
Lead sponsor
AiCure
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2016
Completion date
March 31, 2017
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction, medication non-adherence, opiate addiction, opioid dependence